Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR
Prescription Required
Product introduction
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR is a combination medicine used in the treatment of type 2 diabetes mellitus. It works by delaying glucose absorption, increasing the amount of insulin (glucose lowering hormone), lowering glucose production in the liver, and increasing the body's sensitivity to insulin.
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR is a combination of three antidiabetic medicines: Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR1, Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR2 and Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR3.
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR is a combination of three antidiabetic medicines: Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR1, Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR2 and Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR3.
Uses of Vogli-Rapid M Tablet SR
Benefits of Vogli-Rapid M Tablet SR
In Treatment of Type 2 diabetes mellitus
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. It also slows down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Vogli-Rapid M Tablet SR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Vogli-Rapid M
- Skin rash
- Taste change
- Nausea
- Flatulence
- Diarrhea
- Stomach pain
- Loss of appetite
- Hypoglycemia (low blood glucose level)
How to use Vogli-Rapid M Tablet SR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR is to be taken with food.
How Vogli-Rapid M Tablet SR works
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR is a combination of three antidiabetic medicines: Voglibose, Repaglinide and Metformin. Voglibose suppresses the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose, thereby delaying glucose absorption. Repaglinide increases the amount of insulin (glucose lowering hormone) released from the pancreas during meals. Together, they prevent blood sugar from rising very high after meals. Metformin works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR during breastfeeding is not available. Please consult your doctor.
Driving
CONSULT YOUR DOCTOR
It is not known whether Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CAUTION
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR may be needed. Please consult your doctor.
Liver
CAUTION
Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR is prescribed to control blood sugar and avoid long-term complications.
- Take Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR after you have eaten a meal or with a snack, as this will reduce the chance of an upset stomach.
- It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemia (low blood sugar) symptoms such as fatigue, dizziness, cold sweats, tremor, and anxiety.
- It is important for you to take care of the skin on your lower limbs and to report any sores or signs of infection to your doctor.
- Monitor your blood sugar regularly while taking this medicine.
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
User feedback
Patients taking Vogli-Rapid M 0.3mg/0.5mg/500mg Tablet SR
Once A Day
80%
Thrice A Day
20%
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 24 Apr. 2019] (online) Available from:
- Repaglinide. Gatwick, West Sussex: Novo Nordisk Limited; 2001 [revised May 2016]. [Accessed 24 Apr. 2019] (online) Available from:
- Mayo Clinic. Metformin. [Accessed 24 Apr. 2019] (online) Available from:
Marketer details
Name: Medley Pharmaceuticals
Address: Medley House, D2, M.I.D.C. Area, Andheri (East), Mumbai-400 093, INDIA
Country of origin: India
Lab tests offered by us
Related/Popular tests
19 people viewed this recentlyMRP
₹110
Inclusive of all taxes
10.0 tablet sr in 1 strip
SOLD OUT
Notify me